Decathlon Capital Partners — 2026 Investments

1 investments dated 2026 · listed companies and verified rows first · show all

Amprion, Inc.amprionme.comJul 2026

Amprion offers SAAmplify-αSYN, a clinically validated diagnostic test that detects misfolded (pathological) α-synuclein in cerebrospinal fluid to aid diagnosis of neurodegenerative disorders such as Parkinson's disease, Lewy body dementia, and Alzheimer's.

BiotechDigital HealthMedical Devices

Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.